EGFR and cancer: Overexpression of EGFR is implicated in all aggressive cancers of epithelial origin including squamous cell head & neck (90–100%) [2], glioma (90–100%) [3], non-small cell lung (75–90%), colorectal (80–85%) [4], breast (20–30%) [5] and cervical [6] cancers.